MANDISSA SEALEY: Open Payments
NPI 1760870778 · FLEMINGSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 22 payments from 15 companies in 2025. Trend: 2023 $319 · 2024 $415 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Verona Pharma, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: YUPELRI, CAPLYTA, Wegovy, AIRSUPRA, Ohtuvayre, LOREEV XR, MOUNJARO, GEMTESA.
Industry payments across KY — which companies pay providers there.
